Corporate News     16-Mar-20
USFDA inspects Alembic Pharmaceuticals' Panelav facility
Issues Form 483 with four procedural observations
Alembic Pharmaceuticals announced that US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals General Oral Solid Formulation Facility located at Panelav from 9 March 2020 to 13 March 2020. This was a scheduled inspection and at the end of the inspection, the USFDA issued a Form 483 with four procedural observations.

None of the observations are related to data integrity or repetitive in nature.

The Company will provide comprehensive corrective action report to address each observation. The Company is committed to maintaining highest quality standards that meet USFDA standards.

Previous News
  Market near day's high; metal shares rally for 3rd day
 ( Market Commentary - Mid-Session 01-Jul-24   12:34 )
  Alembic Pharmaceuticals Ltd leads losers in 'A' group
 ( Hot Pursuit - 09-Aug-24   15:00 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
  Alembic Pharma spurts on USFDA nod for leukemia drug
 ( Hot Pursuit - 01-Jul-24   11:06 )
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 16-Jul-24   14:30 )
  Alembic receives USFDA approval for Bromfenac Ophthalmic Solution
 ( Corporate News - 09-Jul-24   15:10 )
  Alembic Pharma gets USFDA nod for Docetaxel injection
 ( Hot Pursuit - 01-Mar-23   11:59 )
  Alembic Pharmaceuticals consolidated net profit declines 18.68% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   14:55 )
  Alembic Pharma gains after USFDA tentative nod for Acalabrutinib capsules
 ( Hot Pursuit - 19-Jan-23   14:12 )
  Alembic Pharmaceuticals receives USFDA's tentative approval for Acalabrutinib Capsules
 ( Corporate News - 19-Jan-23   14:19 )
Other Stories
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
  Blueblood Ventures schedules board meeting
  01-Oct-24   17:39
  CRISIL to discuss results
  01-Oct-24   17:39
  Indian Renewable Energy Deve. Agency to convene board meeting
  01-Oct-24   17:39
  Ashapuri Gold Ornament schedules board meeting
  01-Oct-24   17:38
  Bijoy Hans to conduct board meeting
  01-Oct-24   17:38
  RS Software (India) to announce Quarterly Result
  01-Oct-24   17:38
Back Top